Shanghai, China

Qiuling Zou

This inventor holds 2 USPTO granted patents. Top assignees: Shanghai Mabgeek Biotech. Co., Ltd, Shanghai Mabgeek Biotech. Co., Ltd.. Active years: 2024-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Qiuling Zou

Introduction

Qiuling Zou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions for medical applications, showcasing his expertise and dedication to advancing healthcare.

Latest Patents

Qiuling Zou holds a patent for an "Anti-human MASP-2 antibody, preparation method therefor and application thereof." This invention discloses an antibody that can bind to human MASP-2. The anti-human MASP-2 antibody demonstrates good biological activity by inhibiting the cleavage of C4 and the generation of C3b. It has potential applications in treating MASP-2 related diseases, such as IgA nephropathy. He has 1 patent to his name.

Career Highlights

Qiuling Zou is currently employed at Shanghai Mabgeek Biotech Co., Ltd. His role at the company allows him to engage in cutting-edge research and development. His contributions have been instrumental in advancing the company's mission to innovate in the biotechnology sector.

Collaborations

Qiuling Zou has worked alongside notable colleagues, including Chenghai Zhang and Lingqiao Zhu. Their collaborative efforts have further enhanced the research and development initiatives at their company.

Conclusion

Qiuling Zou's innovative work in biotechnology, particularly with his anti-human MASP-2 antibody, highlights his commitment to improving medical treatments. His contributions are paving the way for advancements in healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…